healthcare organization
GGZ Rivierduinen
NL
People
Connected researchers
Daniella van DamExact authorship linkEls van der VenORCID 0000-0001-5103-7186Hannah JongsmaORCID 0000-0001-6346-5903Jean-Paul SeltenORCID 0000-0003-1591-3243Jean-Paul SeltenExact authorship linkJean‐Paul SeltenExact authorship linkJim van OsORCID 0000-0002-7245-1586Lieuwe de HaanExact authorship linkNathalie FrankeExact authorship link
Public evidence
8 connected articles
Methylomic signature of current cannabis use in two first-episode psychosis cohorts.2025 · Europe PMCThe impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMCCannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMCFirst-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data2023 · PubMed Central Open AccessThe association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.2023 · Europe PMCThe continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open AccessSocial disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study.2021 · PubMed Central Open AccessThe contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.2019 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: OpenAlex.